Skip to content
Riskpilot
← Back to search
Sign in
Get full access
KinexaTherapeutics ApS
APS
Active
Advertising protection
CVR 43952633
Fruebjergvej 3, 2100
København Ø
Research and experimental development on natural sciences and engineering
·
NACE 7210
Est. 2023 · 3 years old
— employees
Monitor
Share
Denmark
/
Companies
/
Research and experimental development on natural sciences and engineering
/
KinexaTherapeutics ApS
Overview
Financials
People & ownership
Related companies
Loading company…
People & ownership
Management
Actively employed in the business
Name
Role
Member since
Current (3)
MB
Mikkel Bender
Management
Management
2023
LJ
Lars Jørgensen
Management
Management
2023
RR
Rune Risgaard
Chief Executive Officer
Chief Executive Officer
2023
Board of directors
Non-executive oversight
No data on file.
Shareholders
As of last annual report
Shareholder
Type
Ownership
Votes
Since
CORIS Holding ApS
Company
33.33–49.99%
33.33–49.99%
2023
MEVA HOLDING ApS
Company
33.33–49.99%
33.33–49.99%
2023
LAJOVI Holding ApS
Company
33.33–49.99%
33.33–49.99%
2023
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive.
Learn more
.
More on KinexaTherapeutics ApS
Overview →
Headline figures, risk assessment and company summary
Financials & key figures →
Revenue, EBITDA, balance sheet and 5-year trend
Related companies →
Corporate hierarchy, parent and subsidiary network
